Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results.
Pilcher CD, Porco TC, Facente SN, Grebe E, Delaney KP, Masciotra S, Kassanjee R, Busch MP, Murphy G, Owen SM, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Pilcher CD, et al. Among authors: welte a. AIDS. 2019 Jun 1;33(7):1231-1240. doi: 10.1097/QAD.0000000000002190. AIDS. 2019. PMID: 30870196 Free PMC article.
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Kassanjee R, et al. Among authors: welte a. AIDS. 2014 Oct 23;28(16):2439-49. doi: 10.1097/QAD.0000000000000429. AIDS. 2014. PMID: 25144218 Free PMC article.
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.
Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, Mckinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Kassanjee R, et al. Among authors: welte a. AIDS. 2016 Sep 24;30(15):2361-71. doi: 10.1097/QAD.0000000000001209. AIDS. 2016. PMID: 27454561 Free PMC article.
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD. Keating SM, et al. Among authors: welte a. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):581-588. doi: 10.1097/QAI.0000000000001146. J Acquir Immune Defic Syndr. 2016. PMID: 27509247 Free PMC article.
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Pilcher CD, Murphy G, Grebe E; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Sempa JB, et al. Among authors: welte a. PLoS One. 2019 Jul 26;14(7):e0220345. doi: 10.1371/journal.pone.0220345. eCollection 2019. PLoS One. 2019. PMID: 31348809 Free PMC article.
Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool.
Grebe E, Facente SN, Bingham J, Pilcher CD, Powrie A, Gerber J, Priede G, Chibawara T, Busch MP, Murphy G, Kassanjee R, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Grebe E, et al. Among authors: welte a. BMC Infect Dis. 2019 Oct 26;19(1):894. doi: 10.1186/s12879-019-4543-9. BMC Infect Dis. 2019. PMID: 31655566 Free PMC article.
A new general biomarker-based incidence estimator.
Kassanjee R, McWalter TA, Bärnighausen T, Welte A. Kassanjee R, et al. Among authors: welte a. Epidemiology. 2012 Sep;23(5):721-8. doi: 10.1097/EDE.0b013e3182576c07. Epidemiology. 2012. PMID: 22627902 Free PMC article.
110 results